Recap: eFFECTOR Therapeutics Q1 Earnings

eFFECTOR Therapeutics EFTR reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:01 PM.

Here's what investors need to know about the announcement.

Earnings

eFFECTOR Therapeutics missed estimated earnings by 71.43%, reporting an EPS of $-0.24 versus an estimate of $-0.14.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 3.41% drop in the share price the next day.

Here's a look at eFFECTOR Therapeutics's past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate -0.24 -0.21 -3.83 -0.24
EPS Actual -0.22 -0.23 -0.17 0.07
Revenue Estimate 660K 640K 520K 350K
Revenue Actual 674K 867K 2.01M 0

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for eFFECTOR Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!